Clinical Trials Logo

Filter by:
NCT ID: NCT00619827 Completed - Clinical trials for Seasonal Allergic Rhinitis

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Start date: September 2007
Phase: Phase 1
Study type: Interventional

The objective of this study is to assess the effect of grass pollen extract SLIT tablets on the Rhinoconjunctivitis Total Symptom Score (RTSS) of the six rhinoconjunctivitis symptoms in response to grass pollen challenge after one week, one, two and four months of treatment in patients suffering from Seasonal Allergic Rhinoconjunctivitis (SAR) due to grass pollen.

NCT ID: NCT00619697 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

EUROMIX
Start date: December 2003
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to investigate the efficacy on blood glucose control in type 2 diabetes.

NCT ID: NCT00619593 Completed - Clinical trials for Sudden Cardiac Death

Survival of Patients With Primary Prophylactic ICD Indication

SPIRIT-ICD
Start date: February 2008
Phase: Phase 4
Study type: Interventional

The MADIT-II trial has shown that patients with severely reduced left ventricular ejection fraction (LVEF) post myocardial infarction benefit from the implantable cardioverter-defibrillator (ICD). However, retrospective analyses of the MADIT-II data have revealed a significantly increased morbidity and mortality in patients with appropriate ICD therapy: Appropriate ICD therapy is associated with 3.3-fold increased all-cause mortality, and the risk of a first heart failure hospitalization is 90% higher after 1st appropriate ICD therapy. Hence, the 1st appropriate therapy might indicate the necessity and utility of further clinical diagnostics and therapy in these patients. This trial is designed to (i) improve the knowledge of the group characteristics of patients suffering from 1st appropriate ICD therapy, (ii) but moreover to take additional therapeutic steps to reduce the mortality of this patient population.

NCT ID: NCT00618137 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Inert Dusts and Pathology of Chronic Obstructive Pulmonary Disease

Start date: January 2007
Phase: N/A
Study type: Observational

The main objective of the study is the exploration of the natural course of COPD and its biological background. To this end, active workers without COPD and workers in functional classes GOLD 0-III are investigated by a combined clinical and molecular approach. The study has been designed as a prospective, intraindividual pilot in 160 male or female volunteers of the greater Vienna Area over a period of three years for each individual volunteer.

NCT ID: NCT00617604 Completed - Clinical trials for De Novo Kidney Transplantation

A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

Start date: December 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether alefacept is effective and well tolerated when used with a combination of tacrolimus, mycophenolate mofetil and steroids versus a combination therapy of placebo, tacrolimus and steroids in the prevention of kidney transplant rejection.

NCT ID: NCT00617578 Completed - Clinical trials for Ventricular Tachycardia, Monomorphic

Fast VT Episodes Are Terminated by ATP One Shot

FavoriteATP
Start date: November 2007
Phase: Phase 4
Study type: Interventional

Many arrhythmias detected in the ventricular fibrillation (VF)-zone picture monomorphic ventricular tachycardia (VT) and, hence, could be terminated by antitachycardia pacing (ATP) treatment. Advantages of successful ATP are the painlessness termination and the shortened duration of arrhythmia. The ATP One Shot algorithm is integrated in the latest family of implantable cardioverter defibrillators (ICDs) from BIOTRONIK (Lumax). It allows a single delivery of ATP before charging capacitors to terminate lethal arrhythmia by painful shock. The present study evaluates the efficacy of the ATP One Shot algorithm for the termination of fast VT episodes. 200 patients with secondary prophylactic ICD indication will be followed for 18 months. Spontaneous episodes detected in the VF-zone of the ICD will be evaluated with regard to cycle length, episode duration and course of device therapy.

NCT ID: NCT00616798 Completed - Schizophrenia Clinical Trials

A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

Start date: March 2008
Phase: Phase 2
Study type: Interventional

This study will determine the efficacy and safety of RO4917838 in patients with schizophrenia who are stable on current antipsychotic treatment (olanzapine, que tiapine, risperidone, paliperidone or aripiprazole) with prominent negative or d isorganized thought symptoms. After a 4 week run in period on their current anti psychotic treatment, patients will be randomized to receive placebo 10mg, 30mg, or 60mg of RO4917838 once daily, p.o., as add-on therapy. The anticipated time o n study treatment is <3 months, and the target sample size is 100-500 individual s.

NCT ID: NCT00615992 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

Start date: April 2007
Phase: N/A
Study type: Observational

The primary goal of this post marketing surveillance (PMS) study is to document the efficacy of Tiotropium (Spiriva) to improve physical activity measured by a score that is recommended in national chronic obstructive pulmonary disease (COPD) guidelines for monitoring the course of the disease.

NCT ID: NCT00615355 Completed - Vitiligo Clinical Trials

Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment

Start date: February 2008
Phase: N/A
Study type: Interventional

The effect of treatment with narrow-band UVB 311 nm after transplantation of harvested autologous epidermal cells on vitiligo lesions will be investigated.

NCT ID: NCT00615264 Completed - Type 1 Diabetes Clinical Trials

Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients

DIA-AID
Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if DiaPep277 can effectively protect the internal production of insulin in patients newly diagnosed with type 1 diabetes, by stopping the immune destruction of insulin-producing beta-cells in the pancreas. DiaPep277 acts on the immune system and is expected to prevent further destruction of the beta-cells by stimulating regulatory responses, without causing immunological suppression.